Form 4: IQVIA Director Acquires 198 Deferred Shares

IQVIA Holdings Inc. Director Colleen A. Goggins reported the acquisition of 198 deferred shares, increasing her beneficial ownership in the company.

Summary

• Colleen A. Goggins, a Director of IQVIA Holdings Inc. (IQV), acquired 198 deferred shares.
• The transaction occurred on February 9, 2026.
• Each deferred share is convertible into one share of IQVIA common stock upon settlement.
• Settlement conditions for the deferred shares include ceasing to be a director, a change in control of the company, or the reporting person's death.
• The price of the underlying common stock at the time of acquisition was $192.67 per share.
• Following this transaction, Ms. Goggins beneficially owns a total of 4,900 deferred shares.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive signal, as an insider's decision to increase their stake typically reflects confidence in the company's prospects, though it is a relatively small transaction in the context of the company's overall market capitalization.

Positives

• A Director, Colleen A. Goggins, increased her beneficial ownership in IQVIA Holdings Inc. by acquiring 198 deferred shares.
• This acquisition, valued at approximately $38,148.66 based on the underlying common stock price of $192.67 per share, signals management's confidence in the company's future prospects.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that insider purchases, such as this acquisition of deferred shares by a director, are often interpreted by the market as a positive signal, indicating management's belief in the company's intrinsic value and future performance within the healthcare technology and clinical research industry.

Stakeholder Impact

• Shareholders may perceive this insider acquisition as a positive sign of management's belief in the company's value and future growth, potentially boosting investor confidence.

Key Dates

Recommendation

While the insider acquisition of deferred shares by a director is a positive signal, indicating confidence in IQVIA's future, this single transaction alone is not sufficient to warrant a 'buy' recommendation. It reinforces a 'hold' position for existing investors, suggesting continued belief in the company's long-term prospects without providing new fundamental catalysts for a strong upward re-rating.

Keywords

IQVIA, IQV, Insider Transaction, Form 4, Director, Deferred Shares, Beneficial Ownership, Colleen Goggins, Healthcare Technology